Home › Blog › First-week plan
Getting Started

Your Genome Results Just Arrived: A First-Week Plan

Your results are in and the reports look overwhelming. Here's a calm, ordered way to spend the first week, starting with backups and ending with family conversations.

Updated October 2026•8 min read
Short answer

Start by downloading and backing up your raw files, then read the summary pages before the detailed reports. Learn what “pathogenic,” “VUS” and “carrier” mean, and don’t change medication or health plans until a clinician or genetic counselor has reviewed anything significant.

Go slowly with third-party uploads, and decide in your own time which relatives need to know.

The email lands, the dashboard unlocks, and suddenly you're looking at hundreds of reports with words like "pathogenic" and "risk allele" scattered through them. It's normal to feel a jolt. The good news: almost nothing in a consumer genome report needs action today. A calm, ordered first week will serve you far better than an anxious first night.

Here's a simple plan. The days are a guide, not a deadline. If you need longer, take it.

The week at a glance

WhenWhat to doWhy it matters
Day 1Download and back up your raw filesYour data is only as safe as the copies you control
Day 1–2Read the summary and the "how to read this report" pagesContext first makes the details far less alarming
Day 2–3Learn the handful of terms that cause most of the worry"Carrier" and "VUS" usually mean much less than they sound
Day 3–5Write down questions; book a clinician or genetic counselor if anything looks significantConsumer findings need professional context and often confirmation
Day 4–6Hold off on third-party uploads until you've read their termsPrivacy and accuracy both vary a lot between tools
Day 6–7Decide whether, when and how to tell familySome findings matter to relatives, but timing is yours

Day 1: Back up your files before you read anything

It sounds backwards, but the first job is housekeeping, not reading. Download every file the company offers. For a whole genome that usually means a VCF (the list of places your DNA differs from the reference), and sometimes the much larger BAM or FASTQ files too. For a genotyping test it's usually a single text file of results.

Why first? Companies change, merge, alter their download options and sometimes delete data on request or on a schedule. Once a copy sits on storage you control, you can read the reports at your own pace without worrying about losing access.

Our guide on how to store and back up your genome files walks through file sizes, encryption and sensible storage options step by step.

Days 1–2: Read the summary before the scary-looking details

Most reports open with an overview, and most companies publish a short guide to reading their results. Read those first. They tell you what the test actually looked at, what it could not see, and how the company decides what to flag.

When you do open the detailed reports, a few habits help:

Days 2–3: The words that cause most of the worry

Clinical labs sort genetic variants into five standard categories set out in 2015 by the American College of Medical Genetics and Genomics and the Association for Molecular Pathology: pathogenic, likely pathogenic, uncertain significance, likely benign and benign. Many consumer reports borrow this language, so it helps to know what each one means.

TermPlain meaningWhat to do with it
Pathogenic / likely pathogenicStrong evidence that this variant can cause or contribute to a conditionTalk to a clinician or genetic counselor; it usually needs confirming in a clinical lab
Variant of uncertain significance (VUS)Not enough evidence yet to say either wayGenerally not something to act on; it may be reclassified later
Likely benign / benignEvidence suggests it's harmlessUsually nothing
CarrierOne copy of a variant linked to a recessive or sex-linked conditionUsually no effect on your own health; may matter for family planning

"Pathogenic" is not a diagnosis. Many pathogenic variants raise risk rather than guarantee illness, and how much they raise it varies widely. A consumer result can also simply be wrong, which is why confirmation matters (more on that below).

A VUS is a question mark, not a warning. When VUS results do get reclassified, they tend to move toward benign: a large 2018 study of hereditary cancer testing at one clinical lab found that most reclassified VUS were downgraded to benign or likely benign. Our explainer on variants of uncertain significance covers why these show up and how reclassification works.

"Carrier" is the most common surprise and usually the least worrying. The US National Human Genome Research Institute describes a carrier as someone who can pass on a variant for a recessive or sex-linked condition but doesn't show symptoms of it. Most people carry a few. It's mainly relevant if you're planning a family.

Days 3–5: Don't change anything yet. Make a list instead

This is the most important rule of the week. Don't stop, start or adjust a medication, change a screening schedule, or make a big health decision based on a consumer report on your own. Pharmacogenomic reports, the ones about how you may process certain drugs, are a particular trap. They can look like instructions, but they aren't prescriptions, and your prescriber needs to weigh them against everything else they know about you.

Instead, start a list:

  1. The exact report name, gene and variant (copy the identifier, often an "rs" number or a position).
  2. What the report says it means, in its own words.
  3. Any family history that seems related.
  4. Your questions, however basic they feel.

Bring that list to your doctor. Our guide on how to bring DNA results to your doctor covers what to print and how to frame the conversation. If a result looks significant, such as a pathogenic variant in a gene linked to cancer or heart conditions, a genetic counselor is often the best first stop. Here's how to decide whether you need a genetic counselor and how to find one.

Why confirmation matters. Professional guidelines from the American College of Medical Genetics and Genomics say clinical genetic testing should be done in a CLIA-approved laboratory and interpreted by qualified specialists. A consumer finding is a reason to ask questions. A clinically confirmed result is what you base decisions on.

Days 4–6: Go slowly with third-party uploads

Within hours of getting raw data, many people upload it to free or cheap interpretation sites. It's tempting, but there are two good reasons to wait until you've read the fine print.

Accuracy. Raw data, especially from genotyping chips, can contain errors at exactly the rare variants these tools love to flag. In a 2018 study published in Genetics in Medicine, a clinical lab retested 49 samples that had come in with variants found in consumer raw data, and 40% of those variants turned out to be false positives. The same work found that some variants flagged as "increased risk" by consumer or third-party tools were classified as benign by clinical labs. Our article on false positives in raw data health reports explains why this happens.

Privacy. Every upload is another copy of your genome somewhere else, under someone else's terms. Before uploading, check who runs the service, whether you can delete your data and whether it's shared with researchers or law enforcement.

If you do use a third-party tool, treat what it finds the same way as everything else this week: a question to bring to a professional, not an answer.

If your results came from a genotyping chip and you're curious what a full genome would add, the difference is real, but more data isn't a substitute for clinical confirmation of a specific finding.

Whole genome sequencing

Want the full 30× genome instead of a partial test?

Dante Labs sequences your whole genome and lets you download the raw FASTQ, BAM and VCF files. When we checked on October 25, 2026, it listed the test from $449 with 90+ reports included and results in 6–8 weeks.

Check Dante’s current offer →Code: GENOME

Affiliate link. Prices and promotions change, and codes may not combine with sitewide sales. Confirm the final price at checkout.

Days 6–7: Decide who in the family to tell

Some findings matter to relatives. A pathogenic variant in a gene linked to an inherited condition may mean parents, siblings or children could carry it too. Other results, like trait reports or a carrier status, may only be relevant to a partner or to siblings planning families.

You don't have to decide everything this week. A few questions help:

Our guide to telling relatives about a genetic finding has practical wording and covers relatives who'd rather not know.

After the first week

By now you have your files backed up, a rough sense of what's in your report, a list of questions and possibly an appointment. That's a good place to be. Genomic interpretation keeps changing as research builds, so it's worth checking back on your results now and then, ideally with a professional who can tell you whether anything important has been reclassified.

Most of all, be gentle with yourself. A genome is a lot of information to take in, and nothing about it needs to be understood in a single week.

Common questions

I saw a “pathogenic” result. Should I panic?

No. A pathogenic result in a consumer report is a reason to talk to a clinician or genetic counselor, not a diagnosis. Many such variants raise risk rather than guarantee illness, and consumer findings should be confirmed in a clinical lab before anyone acts on them.

Is a VUS bad news?

Usually not. A variant of uncertain significance means there isn’t enough evidence yet to call it harmful or harmless. Clinical guidelines generally advise against making medical decisions on a VUS alone.

Can I adjust my medication based on a pharmacogenomic report?

Not on your own. Bring the report to your prescriber or pharmacist, who can weigh it against your history and other medications. Never stop or change a prescribed drug without talking to them first.

Should I upload my raw data to other sites right away?

It’s wise to wait. Third-party tools vary in accuracy and privacy, and raw data can contain false positives at rare variants. Read each service’s terms first and treat any finding as a question for a professional.

Do I have to tell my family about my results?

That’s your decision, and you can take your time. If a confirmed finding could affect relatives’ health, a genetic counselor can help you decide who to tell and how.

Sources and verification

In October 2026 we checked the ACMG/AMP five-tier variant terminology and lab recommendations, the NHGRI definition of a carrier, the 2018 Genetics in Medicine false-positive study, and the 2018 JAMA variant-reclassification study. We didn’t give a single percentage for VUS reclassification because the figure varies by lab and gene, and we didn’t name specific third-party tools.

Medical disclaimer. GenomeTesting.org publishes educational content about genetics and consumer genomic testing. Nothing here is medical advice, a diagnosis, or a substitute for care from a qualified clinician or genetic counsellor. Decisions about testing, treatment, or interpreting your own results should be made with a healthcare professional who can see your full history.

Affiliate disclosure. Some links on this page are affiliate links. If you buy through them we may earn a commission at no extra cost to you. This never changes which products we recommend or what we say about them.